These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 827836)

  • 1. Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.
    Dickinson JM; Mitchison DA
    Tubercle; 1976 Dec; 57(4):251-8. PubMed ID: 827836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
    Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig.
    Dhillon J; Mitchison DA
    Br J Exp Pathol; 1989 Feb; 70(1):103-10. PubMed ID: 2493801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
    Paramasivan CN; Herbert D; Prabhakar R
    Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis].
    Djurisić M; Davidović C; Leposavić M; Jovancvić M; Marković L; Popović S
    Plucne Bolesti Tuberk; 1973; 25(3):251-6. PubMed ID: 4210992
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of rifampicin on experimental tuberculosis in mice. The development of resistance to rifampicin. Therapeutic effects of combinations of different drugs with rifampicin].
    Grumbach F
    Antibiot Chemother; 1970; 16():392-405. PubMed ID: 5002305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
    Sener A; Akçalı A; Karatağ O; Koşar S; Değirmenci Y; Akman T
    Mikrobiyol Bul; 2012 Oct; 46(4):689-94. PubMed ID: 23188583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
    Jenne JW; Beggs WH
    Am Rev Respir Dis; 1973 Jun; 107(6):1013-21. PubMed ID: 4197230
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
    Trakada G; Tsiamita M; Spiropoulos K
    Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
    Nitti V; Ninni A; Natali P
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
    [No Abstract]   [Full Text] [Related]  

  • 15. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
    Nitti V
    Antibiot Chemother; 1970; 16():444-70. PubMed ID: 5002308
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].
    Golychevskaja VI
    G Ital Chemioter; 1972; 19(2):20-2. PubMed ID: 4199029
    [No Abstract]   [Full Text] [Related]  

  • 19. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
    Mitchison DA; Nunn AJ
    Am Rev Respir Dis; 1986 Mar; 133(3):423-30. PubMed ID: 2420242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.